TUCSON, Ariz., July 10 /PRNewswire/ -- Ventana Medical Systems, Inc.
(Nasdaq: VMSI), a leading supplier of automated instrument reagent systems to
histology labs and drug discovery labs worldwide, today announced that it will
hold a conference call on Friday, July 20, 2001, at 10:00 a.m. EDT to discuss
its second-quarter financial and operating results. The call can be accessed
via the Internet live and as a replay at http://www.vcall.com . The webcast will be
available for replay for a period of 30 days.
Ventana develops, manufactures and markets instrument/reagent systems that
automate tissue preparation and slide staining in clinical histology and drug
discovery laboratories worldwide. Ventana's clinical systems are important
tools used in the diagnosis and treatment of cancer and infectious diseases.
Ventana's drug discovery systems are used to accelerate the discovery of new
drug targets and evaluate the safety of new drug compounds.
For more information on Ventana Medical Systems, Inc. via facsimile at no
additional cost, Simply dial 1-800-PRO-INFO and enter the stock symbol "VMSI."
Visit the Ventana Medical Systems, Inc. website at http://www.ventanamed.com
The Molecular Discovery Systems Division has its own website
at http://www.ventanadiscovery.com
SOURCE Ventana Medical Systems, Inc.
 back to top
Related links:
http://www.ventanamed.com
CONTACT:
Christopher Gleeson, President and CEO of
Ventana Medical Systems, Inc., 520-690-3557 ; Analyst Contact,
Kathy Brunson of The Financial Relations Board BSMG Worldwide,
312-640-6696
|
